Heterospecific CD4 help to rescue CD8 T cell killers

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 5974-5980

  De Goër De Herve, Marie Ghislaine ^a   Cariou, Anne ^a   Simonetta, Federico ^a   Taoufik, Yassine ^a,b,c  

^a INSERM   (France)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; KILLER CELL; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR MODEL; ADOPTIVE IMMUNOTHERAPY; ANIMAL; C57BL MOUSE; COCULTURE; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEWIS CARCINOMA; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKIN TRANSPLANTATION; TRANSGENIC MOUSE; TRANSPLANTATION; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNE TOLERANCE; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SKIN TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR CELLS, CULTURED;

EID: 58749113460     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.5974     Document Type: Article

References (38)

1. Williams, M. A., and M. J. Bevan. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25: 171-192.
2. + T lymphocytes. Nature 421: 852-856.
3. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
4. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339. (Pubitemid 36433726)
5. + T cells after acute infection. Nat. Immunol. 5: 927-933.
6. -/- mice. J. Virol. 74: 9762-9765.
7. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662. (Pubitemid 37310924)
8. + T cells via antigen cross-presentation. J. Immunol. 176: 7288-7300.
9. + T cells. Nat. Immunol. 2: 1010-1017.
10. Novy, P., M. Quigley, X. Huang, and Y. Yang. 2007. CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J. Immunol. 179: 8243-8251.
11. + T cell counts. PLoS Med. 4: e96.
12. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170: 477-486. (Pubitemid 36026174)
13. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
14. Brooks, D. G., D. B. McGavern, and M. B. Oldstone. 2006. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J. Clin. Invest. 116: 1675-1685.
15. + T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat. Med. 5: 780-787.
16. Staveley-O'Carroll, K., E. Sotomayor, J. Montgomery, I. Borrello, L. Hwang, S. Fein, D. Pardoll, and H. Levitsky. 1998. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc. Natl. Acad. Sci. USA 95: 1178-1183. (Pubitemid 28124932)
17. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
18. Cuenca, A., F. Cheng, H. Wang, J. Brayer, P. Horna, L. Gu, H. Bien, I. M. Borrello, H. I. Levitsky, and E. M. Sotomayor. 2003. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res. 63: 9007-9015. (Pubitemid 38064082)
19. Zhou, G., Z. Lu, J. D. McCadden, H. I. Levitsky, and A. L. Marson. 2004. Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression. J. Exp. Med. 200: 1581-1592. (Pubitemid 40094182)
20. Day, C. L., and B. D. Walker. 2003. Progress in defining CD4 helper cell responses in chronic viral infections. J. Exp. Med. 198: 1773-1777.
21. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296.
22. Horna, P., A. Cuenca, F. Cheng, J. Brayer, H. W. Wang, I. Borrello, H. Levitsky, and E. M. Sotomayor. 2006. In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity. Blood 107: 2871-2878.
23. Malissen, M., A. Gillet, L. Ardouin, G. Bouvier, J. Trucy, P. Ferrier, E. Vivier, and B. Malissen. 1995. Altered T cell development in mice with a targeted mutation of the CD3-ε gene. EMBO J. 14: 4641-4653.
24. Joncker, N. T., J. Helft, A. Jacquet, V. Premel, and O. Lantz. 2006. Intratumor CD4 T-cell accumulation requires stronger priming than for expansion and lymphokine secretion. Cancer Res. 66: 5443-5451.
25. + T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3: 844-851.
26. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
27. Sena, J., S. S. Wachtel, and G. Murphy. 1976. A comparison of the survival of H-Y incompatible ear, tail, and body skin grafts. Transplantation 21: 412-416.
28. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
29. Bourgeois, C., and C. Tanchot. 2003. Mini-review CD4 T cells are required for CD8 T cell memory generation. Eur. J. Immunol. 33: 3225-3231. (Pubitemid 37541098)
30. + T cell memory. Science 297: 2060-2063.
31. Bach, J. F. 2005. Infections and autoimmune diseases. J. Autoimmun. 25(Suppl.): 74-80.
32. Gerloni, M., S. Xiong, S. Mukerjee, S. P. Schoenberger, M. Croft, and M. Zanetti. 2000. Functional cooperation between T helper cell determinants. Proc. Natl. Acad. Sci. USA 97: 13269-13274.
33. den Haan, J. M., and M. J. Bevan. 2000. A novel helper role for CD4 T cells. Proc. Natl. Acad. Sci. USA 97: 12950-12952.
34. Rus, V., V. Nguyen, R. Puliaev, I. Puliaeva, V. Zernetkina, I. Luzina, J. C. Papadimitriou, and C. S. Via. 2007. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J. Immunol. 178: 3962-3972. (Pubitemid 46417667)
35. Shimizu, K., E. K. Thomas, M. Giedlin, and J. J. Mule. 2001. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res. 61: 2618-2624. (Pubitemid 32685847)
36. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328-332. (Pubitemid 28144092)
37. Schuler, G., B. Schuler-Thurner, and R. M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15: 138-147. (Pubitemid 36287518)
38. + T cell help in cancer immunity and the formulation of novel cancer vaccines. Cancer Immunol. Immunother. 56: 70-80.